Joao A Paulo Selected Research

Pancreatic Diseases (Pancreatic Disease)

10/2015	Global Analysis of Protein Expression and Phosphorylation Levels in Nicotine-Treated Pancreatic Stellate Cells.
9/2014	Nicotine alters the proteome of two human pancreatic duct cell lines.
10/2013	Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).
7/2013	A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.
5/2013	Cross-species analysis of nicotine-induced proteomic alterations in pancreatic cells.
3/2012	Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.
1/2012	Differentiating Branch Duct and Mixed IPMN in Endoscopically Collected Pancreatic Cyst Fluid via Cytokine Analysis.
12/2011	Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joao A Paulo Research Topics

Disease

18	Neoplasms (Cancer) 03/2022 - 09/2014
13	Chronic Pancreatitis 09/2014 - 08/2010
8	Pancreatic Diseases (Pancreatic Disease) 10/2015 - 12/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 03/2012
5	Adenocarcinoma 01/2021 - 09/2014
5	Abdominal Pain (Pain, Abdominal) 03/2013 - 08/2010
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2013
3	Leukemia 01/2021 - 01/2019
3	Infections 01/2021 - 10/2016
3	Inflammation (Inflammations) 01/2020 - 03/2012
3	Fibrosis (Cirrhosis) 09/2014 - 06/2011
2	Glaucoma 10/2022 - 01/2021
2	Multiple Myeloma 03/2022 - 01/2021
2	Starvation 11/2021 - 10/2011
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 12/2016
2	Genomic Instability 01/2018 - 01/2017
2	Cysts 09/2017 - 08/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2015 - 07/2015
2	Pancreatitis 10/2013 - 03/2013
2	Exocrine Pancreatic Insufficiency 01/2013 - 03/2012
2	Pancreatic Cyst 08/2012 - 01/2012
1	Ganglion Cysts (Ganglion) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2022
1	Colonic Neoplasms (Colon Cancer) 03/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2021
1	Iron Deficiencies 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Multiple Sclerosis 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Chromosomal Instability (Chromosome Stability) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Obesity 01/2020
1	Merkel Cell Carcinoma 01/2020

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2011
9	Biomarkers (Surrogate Marker)IBA 10/2013 - 04/2011
5	ProteomeIBA 03/2022 - 08/2011
4	Biological ProductsIBA 01/2022 - 03/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
4	Nicotine FDA Link 01/2018 - 05/2013
4	EnzymesIBA 01/2018 - 01/2012
3	CytokinesIBA 08/2012 - 06/2011
2	Phosphotransferases (Kinase)IBA 10/2022 - 01/2020
2	TropomyosinIBA 10/2022 - 09/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2013
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2022
2	EpitopesIBA 01/2022 - 09/2017
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	FilaminsIBA 01/2021 - 03/2012
2	ChromatinIBA 01/2021 - 01/2020
2	Histones (Histone)IBA 01/2020 - 01/2018
2	UbiquitinIBA 01/2019 - 10/2015
2	Complement System Proteins (Complement)IBA 01/2017 - 12/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2012
2	Secretin FDA Link 03/2013 - 08/2011
2	Inosine Monophosphate (IMP)IBA 08/2012 - 01/2012
1	trkB ReceptorIBA 10/2022
1	Nerve Growth Factors (Neurotrophins)IBA 10/2022
1	Retinaldehyde (Retinal)IBA 10/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2022
1	LipidsIBA 01/2022
1	Histocompatibility Antigens Class IIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	CannabinoidsIBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	IronIBA 01/2021
1	Thalidomide (Thalomid)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Medical MarijuanaIBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	SeleniumIBA 01/2020
1	phosphatidylinositol-3,4-bisphosphate 4-phosphataseIBA 01/2020
1	HeterochromatinIBA 01/2020
1	olaparibIBA 01/2020
1	HMGN1 Protein (HMGN1)IBA 01/2020
1	EuchromatinIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Alanine (L-Alanine)FDA Link 01/2020
1	VimentinIBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020

Therapy/Procedure

9	Therapeutics 03/2022 - 10/2013
2	Immunotherapy 01/2022 - 01/2019
1	Transplantation 01/2020